Sukumar Nagendran, President and Head of R&D, Director at Taysha Gene Therapies, holds 936.41K shares in Taysha Gene Therapies (Ticker: TSHA), holds 34.26K shares in Solid Biosciences (Ticker: SLDB), holds 0.00 shares in AveXis Inc (Ticker: AVXS).
What is the percentage of profitable transactions made by Sukumar Nagendran?
The percentage of profitable transactions made by Sukumar Nagendran is 20%.
What is the average return per transaction made by Sukumar Nagendran?
The average return per transaction made by Sukumar Nagendran is 21.20%.
What stocks does Sukumar Nagendran hold?
Sukumar Nagendran holds: TSHA, AVXS, SLDB stocks.
What was Sukumar Nagendran’s latest transaction?
Sukumar Nagendran latest transaction was an Uninformative Sell of $1.25M.
What was Sukumar Nagendran's most profitable transaction?
Sukumar Nagendran’s most profitable transaction was an Informative Buy of TSHA stock on May 18, 2023. The return on the trade was 341.40%.
What is Sukumar Nagendran's role in Taysha Gene Therapies?
Sukumar Nagendran's role in Taysha Gene Therapies is President and Head of R&D, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.